Cooper C. Collins, Director at TherapeuticsMD, Inc. (TXMD), bought 20,000 shares at $3.84 ($77K) on 2014-06-05, disclosed to the SEC on 2014-06-09.
Open-market purchase of $77k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |